Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lhommé

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
La Revue Du Praticien|September 1, 1990
[Navelbine (vinorelbine): new antitumoral agent. Biarritz, November 2-3, 1989]C Lhommé
Gynecologie, Obstetrique & Fertilite|December 1, 2005
[Assisted reproductive technologies after conservative management of borderline or invasive ovarian tumours]P Morice, C Lhommé
La Revue Du Praticien|June 1, 1997
[First line chemotherapy of epithelial cancers of the ovary]C Lhommé, P Pautier
La Revue Du Praticien|April 1, 1992
[Gestational trophoblastic tumors]J P Droz, C Lhommé
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|February 18, 2004
[Cancer and pregnancy: the medical oncologist's point of view]P Pautier, C Lhommé, P Morice
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Replacement of carboplatin by oxaliplatin may be one solution for patients treated for ovarian carcinoma who are hypersensitive to carboplatinM Gutierrez, P Pautier, C Lhommé
La Revue Du Praticien|October 17, 2001
[Evaluation and treatment of cervical cancer]P Morice, C Haie-Meder, C Lhommé
Bulletin Du Cancer|January 22, 1998
[Medical treatment of ovarian malignant germ cell tumors in the adult]S Culine, C Lhommé, J P Droz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Prophylactic surgery: oophorectomy or adnexectomy?S Delaloge, P Morice, A Chompret, et al.
Bulletin Du Cancer|April 10, 2009
[Prognostic and predictive factors in epithelial ovarian cancer]P Boudou-Rouquette, P Pautier, P Morice, et al.
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
La Revue Du Praticien|September 1, 1990
[Navelbine (vinorelbine): new antitumoral agent. Biarritz, November 2-3, 1989]C Lhommé
Gynecologie, Obstetrique & Fertilite|December 1, 2005
[Assisted reproductive technologies after conservative management of borderline or invasive ovarian tumours]P Morice, C Lhommé
La Revue Du Praticien|June 1, 1997
[First line chemotherapy of epithelial cancers of the ovary]C Lhommé, P Pautier
La Revue Du Praticien|April 1, 1992
[Gestational trophoblastic tumors]J P Droz, C Lhommé
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|February 18, 2004
[Cancer and pregnancy: the medical oncologist's point of view]P Pautier, C Lhommé, P Morice
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Replacement of carboplatin by oxaliplatin may be one solution for patients treated for ovarian carcinoma who are hypersensitive to carboplatinM Gutierrez, P Pautier, C Lhommé
La Revue Du Praticien|October 17, 2001
[Evaluation and treatment of cervical cancer]P Morice, C Haie-Meder, C Lhommé
Bulletin Du Cancer|January 22, 1998
[Medical treatment of ovarian malignant germ cell tumors in the adult]S Culine, C Lhommé, J P Droz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Prophylactic surgery: oophorectomy or adnexectomy?S Delaloge, P Morice, A Chompret, et al.
Bulletin Du Cancer|April 10, 2009
[Prognostic and predictive factors in epithelial ovarian cancer]P Boudou-Rouquette, P Pautier, P Morice, et al.
Pageof 12